Obesity As A Preponderant Cardiovascular Risk – Evidence For Clinical Practice: A Systematic Review
IOSR Journal of Dental and Medical Sciences · 2026-03 · 25 (3) · 67-75
DOI: 10.9790/0853-2503026775 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift IOSR Journal of Dental and Medical Sciences, 2026-03. Verfasst von Maria Elizabeth Ferreira MD und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Objective
To synthesize current evidence on the association between obesity and cardiovascular diseases (CVD), covering pathophysiology, clinical implications, and modern management strategies. Methodology: A systematic review of scientific literature conducted across platforms such as PubMed, Cochrane, and international society guidelines (ESC, ACC, SBC), including studies in English, Spanish, and Portuguese.
Results
Obesity is a multifactorial chronic disease acting through a neuro-hormonal-inflammatory axis. Visceral and epicardial adipose tissue function as active endocrine organs, secreting pro-inflammatory cytokines (IL-6, TNFα) that promote atherogenesis and cardiac remodeling. Clinical Manifestations: Obesity is causally linked to heart failure (specifically HFpEF), atrial fibrillation, coronary artery disease, and premature cardiovascular aging. Diagnosis: Body Mass Index (BMI) alone is insufficient for risk stratification. The inclusion of anthropometric criteria, such as waist circumference and the assessment of intermuscular adipose tissue (IMAT), is recommended. Management: Beyond lifestyle interventions, a new pharmacological era (GLP-1 and GIP agonists) has demonstrated a direct reduction in major adverse cardiovascular events (MACE), as evidenced by the SELECT and SUMMIT trials. Bariatric surgery remains the most effective option for sustained weight loss in severe cases.
Conclusion
Obesity must transition from being viewed merely as a comorbidity to being treated as a direct and modifiable therapeutic target in cardiological practice. A proactive and multidisciplinary management approach is essential to mitigate the global burden of cardiovascular disease.
Zitieren
APA
MD, M. E. F., MD, M. D. M. M., & MD, C. G. P. (2026). Obesity As A Preponderant Cardiovascular Risk – Evidence For Clinical Practice: A Systematic Review. IOSR Journal of Dental and Medical Sciences, 25(3), 67-75. https://doi.org/10.9790/0853-2503026775
Vancouver
MD MEF, MD MDMM, MD CGP. Obesity As A Preponderant Cardiovascular Risk – Evidence For Clinical Practice: A Systematic Review. IOSR Journal of Dental and Medical Sciences. 2026;25(3):67-75. doi:10.9790/0853-2503026775
BibTeX
@article{MD2026,
author = {MD, Maria Elizabeth Ferreira and MD, Maurício De Melo Mattos and MD, Cristina Guimarães Pondè},
title = {Obesity As A Preponderant Cardiovascular Risk – Evidence For Clinical Practice: A Systematic Review},
journal = {IOSR Journal of Dental and Medical Sciences},
year = {2026},
volume = {25},
number = {3},
pages = {67--75},
doi = {10.9790/0853-2503026775}
}
EUVIMED